KR101223364B1 - 비오틴화 16당류, 그의 제조 방법 및 그의 용도 - Google Patents

비오틴화 16당류, 그의 제조 방법 및 그의 용도 Download PDF

Info

Publication number
KR101223364B1
KR101223364B1 KR1020077005500A KR20077005500A KR101223364B1 KR 101223364 B1 KR101223364 B1 KR 101223364B1 KR 1020077005500 A KR1020077005500 A KR 1020077005500A KR 20077005500 A KR20077005500 A KR 20077005500A KR 101223364 B1 KR101223364 B1 KR 101223364B1
Authority
KR
South Korea
Prior art keywords
methyl
glucopyranosyl
tri
sulfonato
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020077005500A
Other languages
English (en)
Korean (ko)
Other versions
KR20070051887A (ko
Inventor
필리페 뒤차우소
쟝 파스카 헤럴
쟝 마르크 헤르베르
모리스 프티토우
피에르 사비
Original Assignee
사노피
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101223364(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 사노피 filed Critical 사노피
Publication of KR20070051887A publication Critical patent/KR20070051887A/ko
Application granted granted Critical
Publication of KR101223364B1 publication Critical patent/KR101223364B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
KR1020077005500A 2004-09-09 2005-09-07 비오틴화 16당류, 그의 제조 방법 및 그의 용도 Expired - Fee Related KR101223364B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
FR0409557 2004-09-09
PCT/FR2005/002218 WO2006030104A1 (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation

Publications (2)

Publication Number Publication Date
KR20070051887A KR20070051887A (ko) 2007-05-18
KR101223364B1 true KR101223364B1 (ko) 2013-01-16

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077005500A Expired - Fee Related KR101223364B1 (ko) 2004-09-09 2005-09-07 비오틴화 16당류, 그의 제조 방법 및 그의 용도

Country Status (38)

Country Link
US (3) US20070270342A1 (https=)
EP (1) EP1791872B1 (https=)
JP (1) JP5108519B2 (https=)
KR (1) KR101223364B1 (https=)
CN (1) CN101039963B (https=)
AR (1) AR051286A1 (https=)
AT (1) ATE420118T1 (https=)
AU (1) AU2005284080B2 (https=)
BR (1) BRPI0515078A (https=)
CA (1) CA2577258C (https=)
CY (1) CY1109126T1 (https=)
DE (1) DE602005012287D1 (https=)
DK (1) DK1791872T3 (https=)
EA (1) EA012587B1 (https=)
EC (1) ECSP077272A (https=)
ES (1) ES2320576T3 (https=)
FR (1) FR2874924B1 (https=)
GT (1) GT200500250A (https=)
HN (1) HN2005000518A (https=)
HR (1) HRP20090180T1 (https=)
IL (1) IL181569A (https=)
MA (1) MA28859B1 (https=)
MX (1) MX2007002875A (https=)
MY (1) MY140666A (https=)
NI (1) NI200700063A (https=)
NO (1) NO20071754L (https=)
PA (1) PA8644201A1 (https=)
PE (1) PE20060663A1 (https=)
PL (1) PL1791872T3 (https=)
PT (1) PT1791872E (https=)
RS (1) RS50762B (https=)
SI (1) SI1791872T1 (https=)
SV (1) SV2006002221A (https=)
TN (1) TNSN07053A1 (https=)
TW (1) TW200612970A (https=)
UY (1) UY29102A1 (https=)
WO (1) WO2006030104A1 (https=)
ZA (1) ZA200702255B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024754A1 (fr) 2000-09-22 2002-03-28 Sanofi-Synthelabo Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024754A1 (fr) 2000-09-22 2002-03-28 Sanofi-Synthelabo Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
IL181569A0 (en) 2007-07-04
ECSP077272A (es) 2007-03-29
IL181569A (en) 2011-08-31
HRP20090180T1 (en) 2009-05-31
PL1791872T3 (pl) 2009-06-30
CY1109126T1 (el) 2014-07-02
CA2577258A1 (fr) 2006-03-23
ZA200702255B (en) 2008-09-25
US20100279960A1 (en) 2010-11-04
GT200500250A (es) 2006-04-10
US20130004551A1 (en) 2013-01-03
EA012587B1 (ru) 2009-10-30
AR051286A1 (es) 2007-01-03
HN2005000518A (es) 2009-06-01
US20070270342A1 (en) 2007-11-22
RS50762B (sr) 2010-08-31
EP1791872A1 (fr) 2007-06-06
PE20060663A1 (es) 2006-08-21
MY140666A (en) 2010-01-15
JP5108519B2 (ja) 2012-12-26
TNSN07053A1 (fr) 2008-06-02
MA28859B1 (fr) 2007-09-03
MX2007002875A (es) 2007-05-16
AU2005284080A1 (en) 2006-03-23
NI200700063A (es) 2008-03-07
SI1791872T1 (sl) 2009-06-30
AU2005284080B2 (en) 2011-10-13
TW200612970A (en) 2006-05-01
PA8644201A1 (es) 2006-05-16
CA2577258C (fr) 2013-05-21
ES2320576T3 (es) 2009-05-25
FR2874924B1 (fr) 2006-12-01
HK1113686A1 (en) 2008-10-10
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
CN101039963B (zh) 2011-07-27
EA200700594A1 (ru) 2007-08-31
JP2008512538A (ja) 2008-04-24
KR20070051887A (ko) 2007-05-18
BRPI0515078A (pt) 2008-07-01
SV2006002221A (es) 2006-01-13
CN101039963A (zh) 2007-09-19
NO20071754L (no) 2007-04-02
UY29102A1 (es) 2006-04-28
WO2006030104A1 (fr) 2006-03-23
PT1791872E (pt) 2009-03-27
DK1791872T3 (da) 2009-05-04
EP1791872B1 (fr) 2009-01-07
US8557968B2 (en) 2013-10-15
ATE420118T1 (de) 2009-01-15
US8703738B2 (en) 2014-04-22

Similar Documents

Publication Publication Date Title
KR100891388B1 (ko) 바이오틴 또는 바이오틴 유도체와의 1 이상의 공유 결합을포함하는 항혈전 활성이 있는 다당류
US8703738B2 (en) Biotinylated hexadecasaccharides, preparation and use thereof
HK1113686B (en) Biotinylated hexadecasaccharides, preparation and use thereof
HK1053316B (en) Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20160111

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20160111

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000